
LENSAR Inc (LNSR) Stock Forecast & Price Target
LENSAR Inc (LNSR) Analyst Ratings
Bulls say
LENSAR is a commercial-stage medical device company with a strong market position in the femtosecond laser system market. With its advanced technologies and focus on providing better visual outcomes and efficiency, the company is well-positioned to continue its impressive top-line growth and potentially improve its bottom line in the future. The recent failed acquisition and spin-off from PDL BioPharma may have caused some uncertainty, but the company's strong financials and market share make it an attractive investment option.
Bears say
LENSAR is facing intense competition from larger, more established companies in the medical device industry, limiting its potential to gain significant market share in the laser cataract surgery market. Additionally, the company's changing ALLY pricing structure and seasonal revenue dynamics may result in instability and declining revenues over the next few years. Lastly, LENSAR's dependence on third-party manufacturers for its ALLY system poses a risk, as any disruptions or issues with these manufacturers could greatly affect the company's operations and financials.
This aggregate rating is based on analysts' research of LENSAR Inc and is not a guaranteed prediction by Public.com or investment advice.
LENSAR Inc (LNSR) Analyst Forecast & Price Prediction
Start investing in LENSAR Inc (LNSR)
Order type
Buy in
Order amount
Est. shares
0 shares